Clinical Trial Update: A New Formulation of Calcitriol (DN-101) in Patients With Advanced Malignancies [Phase 1]

View source ↗

Summary

This document reports the completion of a Phase 1 trial evaluating a new DN-101 calcitriol formulation in patients with advanced malignancies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• DN-101

Snippet

Sponsor: Novacea | Conditions: Neoplasms | Phase 1 | Status: COMPLETED